
zzso zzso a zzso II zzso zzso zzso has been widely used to treat zzso Its clinical application, however, has been hindered by the rise of acquired zzso resistance zzso Here, we report that zzso zzso a novel zzso zzso possesses higher zzso activity than its parent compound zzso in a panel of various human tumor cell zzso More importantly, it was also effective against zzso cells both in zzso and in zzso Using a zzso zzso tumor zzso model that zzso zzso zzso zzso zzso exhibited a zzso higher growth zzso rate versus zzso (5 zzso In contrast, zzso and zzso displayed similar zzso activities in a zzso tumor zzso zzso zzso and cellular mechanism studies revealed that zzso targeted zzso II by zzso zzso II zzso complexes that could directly cause DNA zzso There were two distinct cellular responses to DNA damage zzso by the treatment with zzso at low zzso zzso zzso zzso entry was arrested through the suppression of the activity of zzso zzso 2 complexes via the zzso signaling zzso at high zzso zzso zzso zzso zzso signaling was zzso by the zzso death zzso zzso these data demonstrate the potential value of zzso as an zzso drug candidate that should be further zzso 

